Efficacy in Patients With Previous BCMA CAR T-Cell Therapy
Toxicity, PD, CAR, MM
Nine patients underwent anti-BCMA CAR T-cell therapy before entering this clinical trial, including six patients with relapsed MM and three with PD after anti-BCMA CAR T-cell treatment (Table Response and Toxicity of Anti-GPRC5D CAR T Cells in Patients With Previous Anti-BCMA CAR T-Cell Therapy